Immunomodulatory Therapy in Noninfectious Posterior Uveitis
By: Omar Saleh, MD; Aleksandr Kagan, DO; Yoreh Barak, MD; Henry J. Kaplan, MD, FACS
Four therapies from which to choose.
The Treatment of Choroidal Melanoma: How, Why, When and by Whom?
By: Bertil Damato, MD, PhD, FRCOphth
An ocular oncologist offers his clinical opinions.
Internal Limiting Membrane Peeling in Macular Hole Surgery
By: Noemi Lois, MD, PhD, FRCS(ED); Kurt Spiteri-Cornish, MD, FRCOphth; Laura Ternent, PhD
What clinical and economic evidence exists to
support ILM peeling?
Giant Retinal Tears After Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage
By: Daniel L. Chao, MD, PhD; Marco Gonzalez, MD; Harry W. Flynn, JR., MD
A result of excessive vitreous base shaving?
RPS: From the Podium to the Practice
By: Andrew E. Mathis, PhD, Medical Editor
Our coverage of the 2012 Retinal Physician Symposium continues.
Rebleeding After Diabetic Vitrectomy
By: Jonathan M. Smith, MD; David H. W. Steel, MD
Recurrence of hemorrhage after vitrectomy can be a troublesome complication.
Upfront: From the Editor-in-Chief
By: Peter K. Kaiser, M.D.
To peel or not to peel — That is the question
Subspecialty News
By: Jerry Helzner, Senior Editor
FDA approves Lucentis for DME; Could an
eyedrop treat wet AMD; LCA-causing gene
is Isolated; Five-year follow-up on Lucentis for
RVO; and more
Innovation in Retina
By: Jerry Helzner, Senior Editor
Ocriplasmin: two decades of commitment to a concept.
Coding Q&A
New RAC verteporfin audits are being challenged